Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti
Abstract
:1. Introduction
2. Results
2.1. Medicines Analyzed
2.2. Spectrum Quality
2.3. Quality of Spectrum within a Pack
3. Discussion
4. Materials and Methods
4.1. Quality Testing
4.2. Classification of the Antimicrobials
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- WHO. A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products; World Health Organization: Geneva, Switzerland, 2017; Available online: https://www.who.int/medicines/regulation/ssffc/publications/SE-Study_EN_web.pdf?ua=1 (accessed on 19 May 2020).
- Callister, L.C. Substandard and Falsified Medical Products. MCN Am. J. Matern. Nurs. 2019, 44, 361. [Google Scholar] [CrossRef]
- United Nations Office on Drugs and Crime. Counterfeit Goods: A Bargain or a Costly Mistake? Available online: http://www.unodc.org/toc/en/crimes/counterfeit-goods.html (accessed on 23 June 2020).
- Blease, G. Fake Pharmaceuticals: Bad Medicine: The World’s Drug Supply Is Global. Governments Have Failed to Keep Up. The Economist, 2012. Available online: www.economist.com/node/21564546(accessed on 23 June 2020).
- Liang, B.A. Fade to black: Importation and counterfeit drugs. Am. J. Law Med. 2006, 32, 279–323. [Google Scholar] [CrossRef]
- Blackstone, E.A.; Fuhr, J.P.; Pociask, S. The Health and Economic Effects of Counterfeit Drugs. Am. Health Drug Benefits 2014, 7, 216–224. [Google Scholar] [PubMed]
- Davies, J. Antibiotic resistance and the golden age of microbiology. Upsala J. Med. Sci. 2014, 119, 65–67. [Google Scholar] [CrossRef] [Green Version]
- World Bank Group. Drug-Resistant Infections: A Threat to Our Economic Future; The World Bank Group: Washington, DC, USA, 2017. [Google Scholar]
- Joseph, N.M.; Bhanupriya, B.; Shewade, D.G.; Harish, B.N. Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates. J. Clin. Diagn. Res. 2015, 9, DC08–DC12. [Google Scholar] [CrossRef]
- Lai, C.C.; Wang, C.Y.; Chu, C.; Tan, C.K.; Lu, C.L.; Lee, Y.L.; Huang, Y.T.; Lee, P.-I.; Hsueh, P.-R. Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 30, 265–271. [Google Scholar] [CrossRef] [PubMed]
- Loeffler, J.M.; Garbino, J.; Lew, D.; Harbarth, S.; Rohner, P. Antibiotic Consumption, Bacterial Resistance and their Correlation in a Swiss University Hospital and its Adult Intensive Care Units. Scand. J. Infect. Dis. 2003, 35, 843–850. [Google Scholar] [CrossRef] [PubMed]
- Woolhouse, M.E.J.; Ward, M.; Van Bunnik, B.; Farrar, J. Antimicrobial resistance in humans, livestock and the wider environment. Philos. Trans. R. Soc. B: Boil. Sci. 2015, 370, 20140083. [Google Scholar] [CrossRef]
- O’Brien, T.F. Emergence, Spread, and Environmental Effect of Antimicrobial Resistance: How Use of an Antimicrobial Anywhere Can Increase Resistance to Any Antimicrobial Anywhere Else. Clin. Infect. Dis. 2002, 34, S78–S84. [Google Scholar] [CrossRef] [Green Version]
- King, L.J.; Anderson, L.R.; Blackmore, C.G.; Blackwell, M.J.; Lautner, E.A.; Marcus, L.C.; Meyer, T.E.; Monath, T.P.; Nave, J.E.; Ohle, J.; et al. Executive summary of the AVMA One Health Initiative Task Force report. J. Am. Veter-Med. Assoc. 2008, 233, 259–261. [Google Scholar] [CrossRef]
- Do, N.T.T.; Chuc, N.T.K.; Hoa, N.P.; Hoa, N.Q.; Nguyen, N.T.T.; Loan, H.T.; Toan, T.K.; Phuc, H.D.; Horby, P.W.; Van Yen, N.; et al. Antibiotic sales in rural and urban pharmacies in northern Vietnam: An observational study. BMC Pharmacol. Toxicol. 2014, 15, 6. [Google Scholar] [CrossRef] [Green Version]
- Landers, T.; Ferng, Y.-H.; McLoughlin, J.W.; Barrett, A.E.; Larson, E. Antibiotic identification, use, and self-medication for respiratory illnesses among urban Latinos. J. Am. Acad. Nurse Pr. 2010, 22, 488–495. [Google Scholar] [CrossRef]
- Hoa, N.Q.; Larson, M.; Chuc, N.T.K.; Eriksson, B.; Trung, N.V.; Stålsby, C.L. Antibiotics and paediatric acute respiratory infections in rural Vietnam: Health-care providers’ knowledge, practical competence and reported practice. Trop. Med. Int. Health 2009, 14, 546–555. [Google Scholar] [CrossRef]
- Muri-Gama, A.S.; Figueras, A.; Secoli, S.R. Inappropriately prescribed and over-the-counter antimicrobials in the Brazilian Amazon Basin: We need to promote more rational use even in remote places. PLoS ONE 2018, 13, e0201579. [Google Scholar] [CrossRef] [PubMed]
- Tresànchez-Lacorte, B.; Figueras, A. Medicines in Western Sahara Refugee Camps in Tindouf: Prescriptions and self-medication mixing in the drawer. Glob. Public Health 2020, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Delepierre, A.; Gayot, A.; Carpentier, A. Update on counterfeit antibiotics worldwide; Public health risks. Méd. Mal. Infect. 2012, 42, 247–255. [Google Scholar] [CrossRef] [PubMed]
- Chahal, H.S.; Fort, N.S.; Bero, L.A. Availability, prices and affordability of essential medicines in Haiti. J. Glob. Health 2013, 3, 020405. [Google Scholar] [CrossRef] [PubMed]
- Ghanem, N. Substandard and falsified medicines: Global and local efforts to address a growing problem. Clin. Pharm. 2019. [Google Scholar] [CrossRef] [Green Version]
- Pichini, S.; Rotolo, M.C.; Bellotti, P.; Minutillo, A.; Mastrobattista, L.; Pacifici, R. Quali–quantitative analysis of best selling drugs from pharmacy, street market and traditional herbal medicine: A pilot study of market surveillance in Senegal. J. Pharm. Biomed. Anal. 2015, 104, 62–66. [Google Scholar] [CrossRef]
- Cortez, J.; Rosário, E.; Pires, J.E.; Lopes, J.T.; Francisco, M.; Vlieghe, E.; Brito, M. Antimicrobial storage and antibiotic knowledge in the community: A cross-sectional pilot study in north-western Angola. Int. J. Infect. Dis. 2017, 60, 83–87. [Google Scholar] [CrossRef] [Green Version]
- Hall, J.W.; Bouchard, J.; Bookstaver, P.B.; Haldeman, M.S.; Kishimbo, P.; Mbwanji, G.; Mwakyula, I.; Mwasomola, D.; Seddon, M.; Shaffer, M.; et al. The Mbeya Antimicrobial Stewardship Team: Implementing Antimicrobial Stewardship at a Zonal-Level Hospital in Southern Tanzania. Pharmacy 2020, 8, 107. [Google Scholar] [CrossRef]
- Luczak, A.; Kalyanaraman, R. Portable and Benchtop Raman Technologies for Product Authentication and Counterfeit Detection. Am. Pharm. Rev. 2014, 17, 5. [Google Scholar]
- Bakeev, K.; Chimenti, R. Pros and cons of using correlation versus multivariate algorithms for material identification via handheld spectroscopy. Am. Pharm. Rev. 2013, 16, 10. [Google Scholar]
- Kalyanaraman, R.; Ganesh, V. Finding Fakes. Analytical Scientist 2016. Available online: https://theanalyticalscientist.com/fields-applications/finding-fakes (accessed on 19 May 2020).
- Kalyanaraman, R.; Dobler, G.; Ribick, M. Portable Spectrometers for Pharmaceutical Counterfeit Detection. Am. Pharmaceut Rev. 2010, 13, 38–45. [Google Scholar]
- Visser, B.J.; De Vries, S.G.; Bache, E.B.; Meerveld-Gerrits, J.; Kroon, D.; Boersma, J.; Agnandji, S.T.; Van Vugt, M.; Grobusch, M.P. The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs. Malar. J. 2016, 15, 160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Höllein, L.; Kaale, E.; Mwalwisi, Y.H.; Schulze, M.H.; Holzgrabe, U. Routine quality control of medicines in developing countries: Analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania. TrAC Trends Anal. Chem. 2016, 76, 60–70. [Google Scholar] [CrossRef]
- Kalyanaraman, R.; Dobler, G.; Ribick, M. Near-Infrared (NIR) Spectral Signature Development and Validation for Counterfeit Drug Detection Using Portable Spectrometer. Am. Pharmac. Rev. 2011. Available online: http://www.americanpharmaceuticalreview.com/Featured-Articles/37319-Near-Infrared-NIR-Spectral-Signature-Development-and-Validation-for-Counterfeit-Drug-Detection-Using-Portable-Spectrometer/ (accessed on 24 June 2020).
- Singh, P.K. Access, Watch, Reserve: How a Key Policy Tool Can Accelerate the Fight Against Antimicrobial Resistance. Available online: https://www.who.int/southeastasia/news/opinion-editorials/detail/access-watch-reserve-how-a-key-policy-tool-can-accelerate-the-fight-against-antimicrobial-resistance (accessed on 24 June 2020).
- Hsia, Y.; Lee, B.R.; Versporten, A.; Yang, Y.; Bielicki, J.; Jackson, C.; Newland, J.; Goossens, H.; Magrini, N.; Sharland, M.; et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): An analysis of paediatric survey data from 56 countries. Lancet Glob. Health 2019, 7, e861–e871. [Google Scholar] [CrossRef] [Green Version]
Generic Name | Number of Packs | Number of Units | Price Range * for a Pack in US$ ** | Countries of Origin |
---|---|---|---|---|
Amoxicillin | 58 | 290 | 0.5–0.76 | India (50), China (4), Haiti (1), Not available (3) |
Metronidazole | 42 | 210 | 0.5–1.51 | India (40), China (1), Honduras (1) |
Cotrimoxazole | 28 | 140 | 0.5–6.97 | Kenya (11), China (9), India (7), Not available (1) |
Tetracycline | 21 | 105 | 0.5–0.61 | India (16), USA (5) |
Chloroquine | 16 | 80 | 0.5–1.00 | India (15), France (1) |
Ciprofloxacin | 16 | 80 | 0.5–2.78 | India (9), USA (5), Haiti (1), Canada (1) |
Erythromycin | 7 | 35 | 0.76–1.82 | India (4), Not available (3) |
Azithromycin | 3 | 10 | 0.5–0.76 | India (2), Not available (1) |
Cloxacillin | 3 | 15 | 1.26–1.7 | India (2), Haiti (1) |
Amoxicillin/Clavulanic Acid | 1 | 5 | 1.00 | India (1) |
Clarithromycin | 1 | 5 | 4.04 | India (1) |
AWaRe Classification | Generic Name | Good Match | Poor Match | Total Samples |
---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Access | Amoxicillin | 286 (98.6) | 4 (1.4) | 290 (100) |
Amoxicillin/Clavulanic Acid | - | 5 (100) | 5 (100) | |
Cloxacillin | - | 15 (100) | 15 (100) | |
Cotrimoxazole | 140 (100) | - | 140 (100) | |
Metronidazole | 210 (100) | - | 210 (100) | |
Tetracycline | - | 105 (100) | 105 (100) | |
Subtotal Access | 636 (83.1) | 129 (16.9) | 765 (100) | |
Watch | Azithromycin | - | 10 (100) | 10 (100) |
Ciprofloxacin | 50 (62.5) | 30 (37.5) | 80 (100) | |
Clarithromycin | - | 5 (100) | 5 (100) | |
Erythromycin | - | 35 (100) | 35 (100) | |
Subtotal Watch | 50 (38.4) | 80 (61.5) | 130 (100) | |
̶ | Chloroquine | 71 (88.8) | 9 (11.3) | 80 (100) |
TOTAL | 757 (77.6) | 218 (22.4) | 975 (100) |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jean-Baptiste, T.; Carpenter, J.F.; Dahl, K.; Derameau, W.; Veillard, R.; Jacquet, J.R.; Osselyn, P.L.; Figueras, A. Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti. Antibiotics 2020, 9, 407. https://doi.org/10.3390/antibiotics9070407
Jean-Baptiste T, Carpenter JF, Dahl K, Derameau W, Veillard R, Jacquet JR, Osselyn PL, Figueras A. Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti. Antibiotics. 2020; 9(7):407. https://doi.org/10.3390/antibiotics9070407
Chicago/Turabian StyleJean-Baptiste, Théodule, John F. Carpenter, Kevin Dahl, Wellington Derameau, Rosemela Veillard, John Redford Jacquet, Pierre Ludens Osselyn, and Albert Figueras. 2020. "Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti" Antibiotics 9, no. 7: 407. https://doi.org/10.3390/antibiotics9070407
APA StyleJean-Baptiste, T., Carpenter, J. F., Dahl, K., Derameau, W., Veillard, R., Jacquet, J. R., Osselyn, P. L., & Figueras, A. (2020). Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti. Antibiotics, 9(7), 407. https://doi.org/10.3390/antibiotics9070407